Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q2 EPS of ($0.28), $0.07 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.